University of Antwerp, Department of Pharmaceutical Sciences, Antwerp, Belgium.
J Physiol Pharmacol. 2009 Dec;60 Suppl 6:5-11.
The most well known food-based strategies to modulate the composition of the intestinal microbiota are the dietary use of prebiotics, probiotics and their combination, synbiotics. Currently established prebiotic compounds are mainly targeting the bifidobacteria population of the colon microbiota. A good illustration of the importance of high colonic bifidobacteria levels is the observation that breast milk creates an environment in the colon (because of its high amount in galacto-oligosaccharides with prebiotic activity) favouring the development of a simple flora, dominated by bifidobacteria to which various health benefits have been ascribed. Currently, high colonic bifidobacteria levels has been considered favourably at all ages and strategies to augment their presence have been demonstrated in placebo-controlled intervention studies; e.g. in toddlers to reduce sickness events, in adults to reduce the risk for developing gastrointestinal diseases and in the elderly to re-enhance their declining immune activity. The intestinal microbiota can be considered as a metabolically adaptable and rapidly renewable organ of the body. However, unbalances in its microbial community and activities are found to be implicated in disease initiation and progression, such as chronic inflammatory bowel diseases and colonic cancers. Restoration of this balance by increasing bifidobacteria levels has demonstrated to reduce disease severity of patients and to improve well-being in healtly volunteers. New emerging evidence on the difference in the composition of the colonic microbiota between obese and lean volunteers has opened new areas for pre-, pro- and synbiotic research. Additionally, as knowledge will increase about the microbial bio-conversion of polyphenolic compounds into bioactive metabolites in the colon and whether food-based strategies can augment such bioconversion into more potent compounds with anti-oxidant and/or anti-inflammatory activity new areas of research will be discovered. This paper provides an up-to-date review of the health benefits associated to the induction of high bifidobacteria levels in the colon by the use of prebiotics (inulin and oligofructose). New areas of emerging science will be discussed as well.
最著名的调节肠道微生物群组成的基于食物的策略是使用益生元、益生菌及其组合(合生元)进行饮食。目前已确定的益生元化合物主要针对结肠微生物群中的双歧杆菌种群。母乳喂养在结肠中创造了一个有利于双歧杆菌发展的环境(因为其含有大量具有益生元活性的半乳糖-低聚糖),这很好地说明了结肠中双歧杆菌水平高的重要性,而双歧杆菌被认为具有多种健康益处。目前,人们认为所有年龄段的结肠双歧杆菌水平都很高,并且已经在安慰剂对照干预研究中证明了增加其存在的策略;例如,在幼儿中可以减少疾病发作,在成年人中可以降低患胃肠道疾病的风险,在老年人中可以重新增强其逐渐下降的免疫活性。肠道微生物群可以被认为是一个代谢适应性强且快速可再生的身体器官。然而,其微生物群落和活性的失衡被发现与疾病的发生和进展有关,例如慢性炎症性肠病和结肠癌。通过增加双歧杆菌水平来恢复这种平衡已被证明可以减轻患者的疾病严重程度,并提高健康志愿者的幸福感。肥胖和瘦志愿者结肠微生物群组成差异的新出现证据为前生素、益生菌和合生元研究开辟了新的领域。此外,随着人们对微生物在结肠中将多酚类化合物转化为生物活性代谢物的生物转化的了解不断增加,以及食物策略是否可以增强这种生物转化为具有抗氧化和/或抗炎活性的更有效化合物,新的研究领域将会被发现。本文提供了一篇关于通过使用益生元(菊粉和低聚果糖)在结肠中诱导高双歧杆菌水平相关健康益处的最新综述。还将讨论新兴科学的新领域。